Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mustang Bio stock

Own Mustang Bio stock in just a few minutes.

Posted

Fact checked

Mustang Bio, Inc is a biotechnology business based in the US. Mustang Bio shares (MBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Mustang Bio employs 51 staff and has a market cap (total outstanding shares value) of USD$219.9 million.

How to buy shares in Mustang Bio

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Mustang Bio. Find the stock by name or ticker symbol: MBIO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Mustang Bio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Mustang Bio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Mustang Bio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Mustang Bio share price

Use our graph to track the performance of MBIO stocks over time.

Mustang Bio shares at a glance

Information last updated 2020-11-25.
52-week range USD$1.78 - USD$4.85
50-day moving average USD$3.0201
200-day moving average USD$3.2398
Wall St. target price USD$9
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.325

Buy Mustang Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Mustang Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mustang Bio financials

Gross profit TTM USD$0
Return on assets TTM -38.25%
Return on equity TTM -80.1%
Profit margin 0%
Book value $1.259
Market capitalisation USD$219.9 million

TTM: trailing 12 months

Shorting Mustang Bio shares

There are currently 4.3 million Mustang Bio shares held short by investors – that's known as Mustang Bio's "short interest". This figure is 45% up from 3.0 million last month.

There are a few different ways that this level of interest in shorting Mustang Bio shares can be evaluated.

Mustang Bio's "short interest ratio" (SIR)

Mustang Bio's "short interest ratio" (SIR) is the quantity of Mustang Bio shares currently shorted divided by the average quantity of Mustang Bio shares traded daily (recently around 1.6 million). Mustang Bio's SIR currently stands at 2.67. In other words for every 100,000 Mustang Bio shares traded daily on the market, roughly 2670 shares are currently held short.

However Mustang Bio's short interest can also be evaluated against the total number of Mustang Bio shares, or, against the total number of tradable Mustang Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Mustang Bio's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Mustang Bio shares in existence, roughly 70 shares are currently held short) or 0.0881% of the tradable shares (for every 100,000 tradable Mustang Bio shares, roughly 88 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Mustang Bio.

Find out more about how you can short Mustang Bio stock.

Mustang Bio share dividends

We're not expecting Mustang Bio to pay a dividend over the next 12 months.

Mustang Bio share price volatility

Over the last 12 months, Mustang Bio's shares have ranged in value from as little as $1.78 up to $4.85. A popular way to gauge a stock's volatility is its "beta".

MBIO.US volatility(beta: 1.6)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mustang Bio's is 1.6001. This would suggest that Mustang Bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Mustang Bio overview

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develop MB-107, a gene therapy program, potential curative treatment for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. Its ex vivo lentiviral gene therapy is in two Phase 1/2 clinical trials. The company also develops MB-102, a heterodimeric interleukin-3-receptor for acute myeloid leukemia; MB-106 for immunotherapy of B-cell lymphomas; MB-104, an NK cell receptor regulating immune functions; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has a license agreement with Nationwide Children's Hospital for the development of an oncolytic virus for treating GBM; and Beth Israel Deaconess Medical Center, Inc. to perform research relating to gene editing. The company was incorporated in 2015 and is headquartered in New York, New York. Mustang Bio, Inc. is a subsidiary of Fortress Biotech, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site